Anti-DNAJC30 monoclonal antibody

Pre-made anti-DNAJC30 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DNAJC30/DNAJC30 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0713-Ab-1/ GM-Tg-hg-IP0713-Ab-2Anti-Human DNAJC30 monoclonal antibodyHuman
GM-Tg-rg-IP0713-Ab-1/ GM-Tg-rg-IP0713-Ab-2Anti-Rat DNAJC30 monoclonal antibodyRat
GM-Tg-mg-IP0713-Ab-1/ GM-Tg-mg-IP0713-Ab-2Anti-Mouse DNAJC30 monoclonal antibodyMouse
GM-Tg-cynog-IP0713-Ab-1/ GM-Tg-cynog-IP0713-Ab-2Anti-Cynomolgus/ Rhesus macaque DNAJC30 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0713-Ab-1/ GM-Tg-felg-IP0713-Ab-2Anti-Feline DNAJC30 monoclonal antibodyFeline
GM-Tg-cang-IP0713-Ab-1/ GM-Tg-cang-IP0713-Ab-2Anti-Canine DNAJC30 monoclonal antibodyCanine
GM-Tg-bovg-IP0713-Ab-1/ GM-Tg-bovg-IP0713-Ab-2Anti-Bovine DNAJC30 monoclonal antibodyBovine
GM-Tg-equg-IP0713-Ab-1/ GM-Tg-equg-IP0713-Ab-2Anti-Equine DNAJC30 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0713-Ab-1/ GM-Tg-hg-IP0713-Ab-2; GM-Tg-rg-IP0713-Ab-1/ GM-Tg-rg-IP0713-Ab-2;
GM-Tg-mg-IP0713-Ab-1/ GM-Tg-mg-IP0713-Ab-2; GM-Tg-cynog-IP0713-Ab-1/ GM-Tg-cynog-IP0713-Ab-2;
GM-Tg-felg-IP0713-Ab-1/ GM-Tg-felg-IP0713-Ab-2; GM-Tg-cang-IP0713-Ab-1/ GM-Tg-cang-IP0713-Ab-2;
GM-Tg-bovg-IP0713-Ab-1/ GM-Tg-bovg-IP0713-Ab-2; GM-Tg-equg-IP0713-Ab-1/ GM-Tg-equg-IP0713-Ab-2
Products NameAnti-DNAJC30 monoclonal antibody
Formatmab
Target NameDNAJC30
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DNAJC30 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0713-Ag-1Recombinant multi-species DJC30/ DNAJC30/ WBSCR18 protein


    Target information

    Target IDGM-IP0713
    Target NameDNAJC30
    Gene ID84277,66114,368190,716630,489805,101096865,617118,100146721
    Gene Symbol and Synonyms1300007M11Rik,DNAJC30,LHONAR,MC1DN38,WBSCR18
    Uniprot AccessionQ96LL9
    Uniprot Entry NameDJC30_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000176410
    Target ClassificationN/A

    The target: DNAJC30, gene name: DNAJC30, also named as WBSCR18. This intronless gene encodes a member of the DNAJ molecular chaperone homology domain-containing protein family. This gene is deleted in Williams syndrome, a multisystem developmental disorder caused by the deletion of contiguous genes at 7q11.23. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.